Atlas Trials

Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment

Clinical trial NCT04414514 · TERMINATED

Trial details

NCT number
NCT04414514
Sponsor
Milton S. Hershey Medical Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hidradenitis Suppurativa
Start date
2022-10-13
Primary completion
2024-02-23
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.